BIOFRONTERA INC. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$42M
R&D
$4M
SG&A
$38M
D&A
$138K
Operating Income
$-11M
EBITDA
$-11M
Interest Expense
$-452K
Interest Income
$71K
Other Income/Expense
$385K
Pretax Income
$-11M
Tax Provision
$25K
Net Income
$-11M
Operating Margin
-27.2%
Net Margin
-25.3%
Effective Tax Rate
-0.2%
Deferred Tax Assets
$398K
DTA Valuation Allowance
$50M
Tax Credit Carryforwards
—
NOL Carryforwards
$43M
ETR (Continuing Operations)
-0.3%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
-0.2%
ETR Foreign Differential (pp)
-0.1%
Operating Lease Cost
$790K
Revenue YoY Variation
11.7%
Income YoY Variation
34.1%